Vectus Biosystems Limited (ASX:VBS)
Share Pricing & News Healthcare

AUD 0.705

-0.015 (2.083%)
(As on 2023-02-04 13:22:25 AEDT)
Previous Close Open Close*
0.72 0.705 0.705
Market Cap Dividend Yield (Annualized)
AUD 37.499M 0.00%

Day Range
0.705L 0.705 H
52 WEEK HIGH LOW
0.66L 1.4 H

Chart Price & Information

Last Trade 0.705
Change% -2.0833
52 W H/L 1.400/0.660
EBITDA -3.28M
NPAT After Abnormal Items -3.994M
Equity -3.534M
ROE% 113.01%
Total Liabilities 7.47M
Total Revenue 1.3M
Cash and Cash Equivalents 1.281M

Stock Information

Share price 0.705
Market Cap 37.499M
Price/Gross Cash Flow -15.60
Dividend Yield Excluding Special 0.00%
Ending Shares 36.264M
52-Week Range 1.400-0.660
Gross DPS (AUD) 0
Gross Dividend Yield (Annualized) 0.00%
Earnings Yield 0.000
Net Tangible Asset (NTA) -0.10
P/E ratio 0.000
Sector P/E --
EPS -11.97
EV/EBITDA --
Net Profit Margin (%) --
Gross Cash Flows Per Share -0.07
Net Gearing -133.97%
Sales Per Share 0.00
Book Value Per Share -0.10

Similar Companies

Related Articles

About Company

Vectus Biosystems Limited (VBS) is a public company based at Julius Avenue, North Ryde, Sydney, Australia. Vectus has developed potentially novel treatments for fibrosis and high blood pressure, which include treatment for three of the largest diseases in the fibrotic franchise, namely heart, kidney and liver disease.

Dividends

Ex-Date Net Dividend Frank Flag Period End Date Type Payable

Event Calendar

Event Type Event Date Event Year
Report (Annual) 2023-09-28 2023
Report (Prelim) 2023-08-30 2023
Report (Interim) 2023-02-24 2023